尋找研究成果

在所有內容中搜尋

為 研究成果 進行篩選

搜尋概念
已選取的篩選器

出版年份

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

作者

  • Jacqueline Whang-Peng
2015

Epidermal growth factor receptor (EGFR)-tyrosine Kinase inhibitor treatment and salvage chemotherapy in EGFR-mutated elderly pulmonary adenocarcinoma patients

Tseng, Y. H., Tseng, Y. C., Lin, Y. H., Lee, Y. C., Perng, R. P., Whang-Peng, J. & Chen, Y. M., 六月 8 2015, 於 : Oncologist. 20, 7, p. 758-766 9 p.

研究成果: 雜誌貢獻文章

4 引文 斯高帕斯(Scopus)
2011

A phase II randomized trial of gefitinib alone or with Tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy

Chen, Y. M., Fan, W. C., Tsai, C. M., Liu, S. H., Shih, J. F., Chou, T. Y., Wu, C. H., Chou, K. T., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 六月 2011, 於 : Journal of Thoracic Oncology. 6, 6, p. 1110-1116 7 p.

研究成果: 雜誌貢獻文章

23 引文 斯高帕斯(Scopus)
2016

Induced pluripotent stem cell-conditioned medium suppressed melanoma tumorigenicity through the enhancement of natural-killer cellular immunity

Hsieh, C. T., Luo, Y. H., Chien, C. S., Wu, C. H., Tseng, P. C., Chiou, S. H., Lee, Y. C., Whang-Peng, J. & Chen, Y. M., 一月 1 2016, 於 : Journal of Immunotherapy. 39, 4, p. 153-159 7 p.

研究成果: 雜誌貢獻文章

2 引文 斯高帕斯(Scopus)
2013

The epidermal growth factor receptor-tyrosine kinase inhibitor erahaschanged the causes of death of patients with advanced non-small-cell lung cancer

Wu, W. S., Chen, Y. M., Tsai, C. M., Shih, J. F., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 十二月 1 2013, 於 : Journal of the Chinese Medical Association. 76, 12, p. 682-685 4 p.

研究成果: 雜誌貢獻文章

3 引文 斯高帕斯(Scopus)
2011

Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance status

Chen, Y. M., Shih, J. F., Fan, W. C., Wu, C. H., Chou, K. T., Tsai, C. M., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 五月 2011, 於 : Journal of the Chinese Medical Association. 74, 5, p. 209-214 6 p.

研究成果: 雜誌貢獻文章

14 引文 斯高帕斯(Scopus)
2016

A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma

Luo, Y. H., Tseng, P. C., Lee, Y. C., Perng, R. P., Whang-Peng, J. & Chen, Y. M., 一月 18 2016, 於 : Cancer Biomarkers. 16, 1, p. 19-29 11 p.

研究成果: 雜誌貢獻回顧型文獻

5 引文 斯高帕斯(Scopus)
2012

Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older

Chen, Y. M., Tsai, C. M., Fan, W. C., Shih, J. F., Liu, S. H., Wu, C. H., Chou, T. Y., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 二月 2012, 於 : Journal of Thoracic Oncology. 7, 2, p. 412-418 7 p.

研究成果: 雜誌貢獻文章

52 引文 斯高帕斯(Scopus)
2016
8 引文 斯高帕斯(Scopus)
2011

First-line Systemic Therapy for Metastatic Non-small-cell Lung Cancer - A Review

Chen, Y. M., Whang-Peng, J. & Chen, C. M., 六月 1 2011, 於 : Journal of Experimental and Clinical Medicine. 3, 3, p. 116-120 5 p.

研究成果: 雜誌貢獻回顧型文獻

6 引文 斯高帕斯(Scopus)
2014

Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung

Huang, C. Y., Chen, Y. M., Wu, C. H., Tsai, C. M., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 一月 1 2014, 於 : Oncology Letters. 7, 6, p. 2180-2184 5 p.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)
2011

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan

Chen, J. S., Chao, Y., Hsieh, R. K., Cheng, A. L., Chen, P. M., Chiou, T. J., Chao, T. Y., Yeh, K. H., Chen, L. T. & Whang-Peng, J., 六月 2011, 於 : Cancer Chemotherapy and Pharmacology. 67, 6, p. 1281-1289 9 p.

研究成果: 雜誌貢獻文章

6 引文 斯高帕斯(Scopus)
2019

Hematuria induced by combination regorafenib and hyperthermia–a radiation recall effect

Zheng, Y. M., Chow, J. M., Chang, C. L., Chao, L. H., Whang-Peng, J. & Lai, G. M., 一月 1 2019, 於 : International Journal of Hyperthermia. 36, 1, p. 1186-1189 4 p.

研究成果: 雜誌貢獻快報

開啟存取
2012

A novel synthetic bipartite carrier protein for developing glycotope-based vaccines

Chiang, H. L., Lin, C. Y., Jan, F. D., Lin, Y. S., Hsu, C. T., Whang-Peng, J., Liu, L. F., Nieh, S., Lin, C. C. & Hwang, J., 十二月 14 2012, 於 : Vaccine. 30, 52, p. 7573-7581 9 p.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2016
21 引文 斯高帕斯(Scopus)
2018

Heteronemin induces anti-Proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway

Lin, H. Y., Tey, S. L., Ho, Y., Chin, Y. T., Wang, K., Whang-Peng, J., Shih, Y. J., Chen, Y. R., Yang, Y. N., Chen, Y. C., Liu, Y. C., Tang, H. Y. & Yang, Y. C. SH., 十二月 6 2018, 於 : Marine Drugs. 16, 12, 489.

研究成果: 雜誌貢獻文章

4 引文 斯高帕斯(Scopus)

Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer

Nana, A. W., Chin, Y. T., Lin, C. Y., Ho, Y., Bennett, J. A., Shih, Y. J., Chen, Y. R., Changou, C. A., Pedersen, J. Z., Incerpi, S., Liu, L. F., Whang-Peng, J., Fu, E., Li, W. S., Mousa, S. A., Lin, H. Y. & Davis, P. J., 三月 1 2018, 於 : Endocrine-Related Cancer. 25, 3, p. 279-293 15 p.

研究成果: 雜誌貢獻文章

14 引文 斯高帕斯(Scopus)
2014

A vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit

Liaw, Y. W., Lin, C. Y., Lai, Y. S., Yang, T. C., Wang, C. J., Whang-Peng, J., Liu, L. F., Lin, C. P., Nieh, S., Lu, S. C. & Hwang, J., 十二月 8 2014, 於 : PLoS One. 9, 12, e111529.

研究成果: 雜誌貢獻文章

23 引文 斯高帕斯(Scopus)

Reconstruction of exposed cohort and cumulative dose of radio-contaminated building residents for epidemiological study - Updated information

Chiang, S-O., Chen, C-H., Tung, C-J., Chou, P., Whang-Peng, J., Chiou, H-Y., Chen, C-J., Chen, Y. H., Yu, L-H., Chang, J-Y., Jyuhn-Hsiarn Lee, L. & Liou, S-H., 2014, 於 : Occupational and Environmental Medicine. 71, Suppl 1, p. A69

研究成果: 雜誌貢獻文章

2019

Epigenetic modification and differentiation induction of malignant glioma cells by oligo-fucoidan

Liao, C. H., Lai, I. C., Kuo, H. C., Chuang, S. E., Lee, H. L., Whang-Peng, J., Yao, C. J. & Lai, G. M., 九月 8 2019, 於 : Marine Drugs. 17, 9, 525.

研究成果: 雜誌貢獻文章

開啟存取
2 引文 斯高帕斯(Scopus)
2020

Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells

Huang, C. H., Huang, T. Y., Chang, W. J., Pan, Y. S., Chu, H. R., Li, Z. L., Unson, S., Chin, Y. T., Lin, C. Y., Huang, H. M., Hsiung, C. N., Gionfra, F., De Vito, P., Pedersen, J. Z., Incerpi, S., Chen, Y. R., Lee, S. Y., Lin, H. Y., Davis, P. J., Whang-Peng, J. 及其他1, Wang, K., 七月 2 2020, 於 : Marine Drugs. 18, 7, 348.

研究成果: 雜誌貢獻文章

開啟存取

Integrin αvβ3 in the mediating effects of dihydrotestosterone and resveratrol on breast cancer cell proliferation

Ho, Y., Zi-Lin, L., Ya-Jung, S., Yi-Ru, C., Wang, K., Whang-Peng, J., Hung-Yun, L. & Davis, P. J., 四月 21 2020, 於 : International Journal of Molecular Sciences. 21, 8, 2906.

研究成果: 雜誌貢獻文章

開啟存取
1 引文 斯高帕斯(Scopus)
2019

Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status

Chin, Y-T., He, Z-R., Chen, C-L., Chu, H-C., Ho, Y., Su, P-Y., Yang, Y-C. S. H., Wang, K., Shih, Y-J., Chen, Y-R., Pedersen, J. Z., Incerpi, S., Nana, A. W., Tang, H-Y., Lin, H-Y., Mousa, S. A., Davis, P. J. & Whang-Peng, J., 一月 1 2019, 於 : Frontiers in Endocrinology. 10, APR, p. 130 130.

研究成果: 雜誌貢獻文章

4 引文 斯高帕斯(Scopus)
2018

Inhibitory effect of Anoectochilus formosanus extract on hyperglycemia-related PD-L1 expression and cancer proliferation

Ho, Y., Chen, Y. F., Wang, L. H., Hsu, K. Y., Chin, Y. T., Yang, Y. C. S. H., Wang, S. H., Chen, Y. R., Shih, Y. J., Liu, L. F., Wang, K., Whang-Peng, J., Tang, H. Y., Lin, H. Y., Liu, H. L. & Lin, S. J., 八月 2 2018, 於 : Frontiers in Pharmacology. 9, AUG, p. 807 807.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2017

Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung

Luo, Y. H., Wu, C. H., Huang, C. Y., Wu, C. W., Wu, W. S., Lee, Y. C., Whang-Peng, J. & Chen, Y. M., 十月 1 2017, 於 : Asia-Pacific Journal of Clinical Oncology. 13, 5, p. e440-e448

研究成果: 雜誌貢獻文章

3 引文 斯高帕斯(Scopus)
2015

ABCG2 Localizes to the Nucleus and Modulates CDH1 Expression in Lung Cancer Cells

Liang, S. C., Yang, C. Y., Tseng, J. Y., Wang, H. L., Tung, C. Y., Liu, H. W., Chen, C. Y., Yeh, Y. C., Chou, T. Y., Yang, M. H., Whang-Peng, J. & Lin, C. H., 三月 1 2015, 於 : Neoplasia. 17, 3, p. 265-278 14 p.

研究成果: 雜誌貢獻文章

26 引文 斯高帕斯(Scopus)
2011
33 引文 斯高帕斯(Scopus)
2014

Reciprocal relationship of Tn/NF-κB and sTn as an indicator of the prognosis of oral squamous cell carcinoma

Lin, C. Y., Ho, J. Y., Hsieh, M. T., Chiang, H. L., Chuang, J. M., Whang-Peng, J., Chang, Y. C., Tseng, Y. H., Chen, S. F., Nieh, S. & Hwang, J-L., 2014, 於 : Histopathology. 64, 5, p. 713-721 9 p.

研究成果: 雜誌貢獻文章

4 引文 斯高帕斯(Scopus)
2016

A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung

Liu, K. J., Chao, T. Y., Chang, J. Y., Cheng, A. L., Ch'Ang, H. J., Kao, W. Y., Wu, Y. C., Yu, W. L., Chung, T. R. & Whang-Peng, J., 八月 24 2016, 於 : Journal of Biomedical Science. 23, 1, 64.

研究成果: 雜誌貢獻文章

6 引文 斯高帕斯(Scopus)
2018

Roles of Resveratrol as Signaling Sensor and Gatekeeper

Shih, Y-J., Chen, Y. R., Wang, K., Whang-Peng, J., Tang, H. Y., Lin, H-Y. & Davis, P. J., 2018, Resveratrol: State-of-the-Art Science and Health Applications. World Scientific Publishing Co., p. 115-144

研究成果: 書貢獻/報告類型章節(同行評審)

2015

Fucoidan elevates MicroRNA-29b to regulate DNMT3B-MTSS1 axis and inhibit EMT in human hepatocellular carcinoma cells

Yan, M. D., Yao, C. J., Chow, J. M., Chang, C. L., Hwang, P. A., Chuang, S. E., Whang-Peng, J. & Lai, G. M., 十月 1 2015, 於 : Marine Drugs. 13, 10, p. 6099-6116 18 p.

研究成果: 雜誌貢獻文章

48 引文 斯高帕斯(Scopus)
2013
31 引文 斯高帕斯(Scopus)
2018

Opposite regulation of CHOP and GRP78 and synergistic apoptosis induction by selenium yeast and fish oil via AMPK activation in lung adenocarcinoma cells

Kao, R. H., Lai, G. M., Chow, J. M., Liao, C. H., Zheng, Y. M., Tsai, W. L., Hsia, S., Lai, I. C., Lee, H. L., Chuang, S. E., Whang-Peng, J. & Yao, C. J., 十月 8 2018, 於 : Nutrients. 10, 10, 1458.

研究成果: 雜誌貢獻文章

2 引文 斯高帕斯(Scopus)

Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R

Ho, Y., SH Yang, Y. C., Chin, Y. T., Chou, S. Y., Chen, Y. R., Shih, Y. J., Whang-Peng, J., Changou, C. A., Liu, H. L., Lin, S. J., Tang, H. Y., Lin, H. Y. & Davis, P. J., 十月 1 2018, 於 : Food and Chemical Toxicology. 120, p. 346-355 10 p.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2013

The Aurora Kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme

Lee, P. Y., Chen, C. L., Lin, Z. Z., Cheng, A. L., Chen, E. I. T., Whang-Peng, J. & Huang, C. Y. F., 六月 2013, 於 : Oncology. 84, 6, p. 326-335 10 p.

研究成果: 雜誌貢獻文章

9 引文 斯高帕斯(Scopus)
2019

Leptin-derived peptides block leptin-induced proliferation by reducing expression of pro-inflammatory genes in hepatocellular carcinoma cells

Ho, Y., Wang, S. H., Chen, Y. R., Li, Z. L., Chin, Y. T., Yang, Y. C. S. H., Wu, Y. H., Su, K. W., Chu, H. R., Chiu, H. C., Crawford, D. R., Shih, Y. J., Grasso, P., Tang, H. Y., Lin, H. Y., Davis, P. J., Whang-Peng, J. & Wang, K., 十一月 1 2019, 於 : Food and Chemical Toxicology. 133, p. 110808 110808.

研究成果: 雜誌貢獻文章

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Chin, Y. T., He, Z. R., Chen, C. L., Chu, H. C., Ho, Y., Su, P. Y., Yang, Y. C. S. H., Wang, K., Shih, Y. J., Chen, Y. R., Pedersen, J. Z., Incerpi, S., Nana, A. W., Tang, H. Y., Lin, H. Y., Mousa, S. A., Davis, P. J. & Whang-Peng, J., 一月 1 2019, 於 : Frontiers in Endocrinology. 10, APR, p. 241 241.

研究成果: 雜誌貢獻文章

開啟存取
1 引文 斯高帕斯(Scopus)
2018

Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers

Nana, A. W., Wu, S. Y., Yang, Y. C. S., Chin, Y. T., Cheng, T. M., Ho, Y., Li, W. S., Liao, Y. M., Chen, Y. R., Shih, Y. J., Liu, Y. R., Pedersen, J., Incerpi, S., Hercbergs, A., Liu, L. F., Whang-Peng, J., Davis, P. J. & Lin, H. Y., 十月 1 2018, 於 : Hormones and Cancer. 9, 5, p. 349-360 12 p.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2015

Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data

Cheng, H. W., Liang, Y. H., Kuo, Y. L., Chuu, C. P., Lin, C. Y., Lee, M. H., Wu, A. T. H., Yeh, C-T., Chen, E. T., Whang-Peng, J., Su, C. L. & Huang, C. Y. F., 五月 1 2015, 於 : Cell Death and Disease. 6, 5, e1753.

研究成果: 雜誌貢獻文章

61 引文 斯高帕斯(Scopus)
2017

Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways

Huang, Y. J., Yang, C. K., Wei, P. L., Huynh, T. T., Whang-Peng, J., Meng, T. C., Hsiao, M., Tzeng, Y. M., Wu, A. T. & Yen, Y., 二月 28 2017, 於 : Journal of hematology & oncology. 10, 1, p. 60 1 p.

研究成果: 雜誌貢獻文章

24 引文 斯高帕斯(Scopus)
2014

A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis

Zhang, K., Lin, J. W., Wang, J., Wu, X., Gao, H., Hsieh, Y. C., Hwu, P., Liu, Y. R., Su, L., Chiou, H. Y., Wang, D., Yuan, Y. C., Whang-Peng, J., Chiu, W. T. & Yen, Y., 十月 1 2014, 於 : Genetics in Medicine. 16, 10, p. 787-792 6 p.

研究成果: 雜誌貢獻文章

12 引文 斯高帕斯(Scopus)
2017

Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells

Hsieh, M. T., Wang, L. M., Changou, C. A., Chin, Y. T., Yang, Y. C. S. H., Lai, H. Y., Lee, S. Y., Yang, Y. N., Whang-Peng, J., Liu, L. F., Lin, H. Y., Mousa, S. A. & Davis, P. J., 2017, 於 : Oncotarget. 8, 15, p. 24237-24249 13 p.

研究成果: 雜誌貢獻文章

19 引文 斯高帕斯(Scopus)

Therapeutic applications of resveratrol and its derivatives on periodontitis

Chin, Y. T., Cheng, G. Y., Shih, Y. J., Lin, C. Y., Lin, S. J., Lai, H. Y., Whang-Peng, J., Chiu, H. C., Lee, S. Y., Fu, E., Tang, H. Y., Lin, H. Y. & Liu, L. F., 九月 1 2017, 於 : Annals of the New York Academy of Sciences. 1403, 1, p. 101-108 8 p.

研究成果: 雜誌貢獻回顧型文獻

11 引文 斯高帕斯(Scopus)
2018

Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation

Chang, T. C., Chin, Y. T., Nana, A. W., Wang, S. H., Liao, Y. M., Chen, Y. R., Shih, Y. J., Changou, C. A., Yang, Y. C. S., Wang, K., Whang-Peng, J., Wang, L. S., Stain, S. C., Shih, A., Lin, H. Y., Wu, C. H. & Davis, P. J., 十二月 1 2018, 於 : Hormones and Cancer. 9, 6, p. 420-432 13 p.

研究成果: 雜誌貢獻文章

6 引文 斯高帕斯(Scopus)

Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells

Lin, S. J., Chin, Y. T., Ho, Y., Chou, S. Y., Sh Yang, Y. C., Nana, A. W., Su, K. W., Lim, Y. T., Wang, K., Lee, SY. Y., Shih, Y. J., Chen, Y. R., Whang-Peng, J., Davis, P. J., Lin, H. Y. & Fu, E., 十月 1 2018, 於 : Food and Chemical Toxicology. 120, p. 1-11 11 p.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2015

The association between tumor epidermal growth factor receptor (EGFR) mutation and multiple primary malignancies in patients with adenocarcinoma of the lungs

Luo, Y. H., Ho, H. L., Tsai, C. M., Shih, J. F., Chiu, C. H., Lai, S. L., Lee, Y. C., Perng, R. P., Whang-Peng, J., Chou, T. Y. & Chen, Y. M., 一月 1 2015, 於 : American Journal of Clinical Oncology: Cancer Clinical Trials. 38, 2, p. 147-151 5 p.

研究成果: 雜誌貢獻回顧型文獻

6 引文 斯高帕斯(Scopus)
2016

Adjuvant therapy for thymic carcinoma - A decade of experience in a Taiwan national teaching hospital

Tseng, Y. H., Lin, Y. H., Tseng, Y. C., Lee, Y. C., Wu, Y. C., Hsu, W. H., Yen, S. H., Whang-Peng, J. & Chen, Y. M., 一月 12 2016, 於 : PLoS One. 11, 1, e0146609.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)
2018

PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non–Small Cell Lung Cancer Patients with Malignant Pleural Effusion

Tseng, Y. H., Ho, H. L., Lai, C. R., Luo, Y. H., Tseng, Y. C., Whang-Peng, J., Lin, Y. H., Chou, T. Y. & Chen, Y. M., 三月 1 2018, 於 : Journal of Thoracic Oncology. 13, 3, p. 447-453 7 p.

研究成果: 雜誌貢獻文章

10 引文 斯高帕斯(Scopus)
2014

Number of liver metastatic nodules affects treatment options for pulmonary adenocarcinoma patients with liver metastases

Tseng, S. E., Chiou, Y. Y., Lee, Y. C., Perng, R. P., Jacqueline, W. P. & Chen, Y. M., 一月 1 2014, 於 : Lung Cancer. 86, 2, p. 225-230 6 p.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)
2012

Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib

Chen, Y. M., Fan, W. C., Tseng, P. C., Tsai, C. M., Chou, T. Y., Wu, C. H., Chou, K. T., Lee, Y. C., Perng, R. P. & Whang-Peng, J., 三月 2012, 於 : Oncology Letters. 3, 3, p. 713-717 5 p.

研究成果: 雜誌貢獻文章

9 引文 斯高帕斯(Scopus)

Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection

Chen, L. T., Chen, M. F., Li, L. A., Lee, P. H., Jeng, L. B., Lin, D. Y., Wu, C. C., Mok, K. T., Chen, C. L., Lee, W-C., Chau, G. Y., Chen, Y. S., Lui, W. Y., Hsiao, C. F., Whang-Peng, J. & Chen, P. J., 2012, 於 : Annals of Surgery. 255, 1, p. 8-17 10 p.

研究成果: 雜誌貢獻文章

79 引文 斯高帕斯(Scopus)